Literature DB >> 11226282

BLNK mediates Syk-dependent Btk activation.

Y Baba1, S Hashimoto, M Matsushita, D Watanabe, T Kishimoto, T Kurosaki, S Tsukada.   

Abstract

Btk is a critical molecule in B cell antigen receptor (BCR)-coupled signaling, and its activity is regulated by Lyn and Syk. Although the molecular mechanism of Lyn-dependent Btk activation has been investigated, that of Syk-dependent Btk activation has remained unidentified. We have demonstrated that BLNK mediates Syk-dependent Btk activation. In a reconstitution cell system, coexpression of BLNK allows Syk to phosphorylate Btk on its tyrosine 551, leading to the enhancement of Btk activity. This phosphorylation depends on the interaction of Btk and BLNK by means of the Btk-Src homology 2 domain. The existence of such an activation mechanism is supported by the observation that the BCR-induced Btk phosphorylation and activation are significantly reduced in BLNK-deficient B cells as well as in Syk-deficient B cells. Although previous observations have identified the function of BLNK as the linker that integrates the action of Btk and Syk into downstream effectors such as phospholipase Cgamma2, our present study indicates another function of BLNK that connects the activity of Syk to that of Btk.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226282      PMCID: PMC30181          DOI: 10.1073/pnas.051626198

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Tec kinases: a family with multiple roles in immunity.

Authors:  W C Yang; Y Collette; J A Nunès; D Olive
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

Review 2.  BLNK: connecting Syk and Btk to calcium signals.

Authors:  T Kurosaki; S Tsukada
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

3.  Interaction of SLP adaptors with the SH2 domain of Tec family kinases.

Authors:  Y W Su; Y Zhang; J Schweikert; G A Koretzky; M Reth; J Wienands
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

4.  Catalytic specificity of phosphotyrosine kinases Blk, Lyn, c-Src and Syk as assessed by phage display.

Authors:  R Schmitz; G Baumann; H Gram
Journal:  J Mol Biol       Date:  1996-08-02       Impact factor: 5.469

5.  A BASH/SLP-76-related adaptor protein MIST/Clnk involved in IgE receptor-mediated mast cell degranulation.

Authors:  R Goitsuka; H Kanazashi; H Sasanuma; Y Fujimura; Y Hidaka; A Tatsuno; C Ra; K Hayashi; D Kitamura
Journal:  Int Immunol       Date:  2000-04       Impact factor: 4.823

Review 6.  Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor.

Authors:  R C Hsueh; R H Scheuermann
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

7.  Regulation of protein kinase CbetaI by two protein-tyrosine kinases, Btk and Syk.

Authors:  Y Kawakami; J Kitaura; S E Hartman; C A Lowell; R P Siraganian; T Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

8.  TCR/CD3-Induced activation and binding of Emt/Itk to linker of activated T cell complexes: requirement for the Src homology 2 domain.

Authors:  K A Ching; J A Grasis; P Tailor; Y Kawakami; T Kawakami; C D Tsoukas
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

9.  Involvement of LAT, Gads, and Grb2 in compartmentation of SLP-76 to the plasma membrane.

Authors:  M Ishiai; M Kurosaki; K Inabe; A C Chan; K Sugamura; T Kurosaki
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

Review 10.  Tyrosine kinase SYK: essential functions for immunoreceptor signalling.

Authors:  M Turner; E Schweighoffer; F Colucci; J P Di Santo; V L Tybulewicz
Journal:  Immunol Today       Date:  2000-03
View more
  48 in total

1.  BLNK: molecular scaffolding through 'cis'-mediated organization of signaling proteins.

Authors:  Christopher W Chiu; Mark Dalton; Masamichi Ishiai; Tomohiro Kurosaki; Andrew C Chan
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

2.  CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques.

Authors:  Jessica E Taaffe; Steven E Bosinger; Gregory Q Del Prete; James G Else; Sarah Ratcliffe; Christopher D Ward; Thi Migone; Mirko Paiardini; Guido Silvestri
Journal:  J Med Primatol       Date:  2011-11-14       Impact factor: 0.667

Review 3.  Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia.

Authors:  Kumudha Balakrishnan; Varsha Gandhi
Journal:  Expert Opin Investig Drugs       Date:  2012-03-09       Impact factor: 6.206

4.  Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates.

Authors:  Liang Xue; Wen-Horng Wang; Anton Iliuk; Lianghai Hu; Jacob A Galan; Shuai Yu; Michael Hans; Robert L Geahlen; W Andy Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

Review 5.  Dual role of the adaptor protein SLP-65: organizer of signal transduction and tumor suppressor of pre-B cell leukemia.

Authors:  Sebastian Herzog; Bettina Storch; Hassan Jumaa
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

6.  SLP-65 phosphorylation dynamics reveals a functional basis for signal integration by receptor-proximal adaptor proteins.

Authors:  Thomas Oellerich; Mads Grønborg; Konstantin Neumann; He-Hsuan Hsiao; Henning Urlaub; Jürgen Wienands
Journal:  Mol Cell Proteomics       Date:  2009-04-16       Impact factor: 5.911

7.  Identification of direct tyrosine kinase substrates based on protein kinase assay-linked phosphoproteomics.

Authors:  Liang Xue; Robert L Geahlen; W Andy Tao
Journal:  Mol Cell Proteomics       Date:  2013-06-22       Impact factor: 5.911

Review 8.  Targeting B-cell receptor signaling in leukemia and lymphoma: how and why?

Authors:  John C Allen; Fatima Talab; Joseph R Slupsky
Journal:  Int J Hematol Oncol       Date:  2016-05-26

Review 9.  Phosphodiesterase 4 inhibitors have wide-ranging activity in B-cell malignancies.

Authors:  Jeffrey D Cooney; Ricardo C T Aguiar
Journal:  Blood       Date:  2016-10-18       Impact factor: 22.113

10.  Coupling of STIM1 to store-operated Ca2+ entry through its constitutive and inducible movement in the endoplasmic reticulum.

Authors:  Yoshihiro Baba; Kenji Hayashi; Yoko Fujii; Akiko Mizushima; Hiroshi Watarai; Minoru Wakamori; Takuro Numaga; Yasuo Mori; Masamitsu Iino; Masaki Hikida; Tomohiro Kurosaki
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.